The appearance of Tregs in cancer nest is a promising independent risk factor in colon cancer
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Purpose To investigate the prognostic value of tumor-infiltrating regulatory T cells (Tregs) in the distribution of cancer nest, cancer stroma and normal mucosa and FOXP3-positive cancer cells in colon cancer patients after resection. Methods Paraffin blocks of operation resection of primary adenocarcinoma of colon were obtained from ninety patients. The distribution of tumor-infiltrating Tregs was detected by tissue microarray and immunohistochemistry staining technique to evaluate the prognostic effects by Kaplan-Meier and Cox regression analysis using median values as cutoff. Results The intratumoral Tregs counts were significantly higher than that in corresponding normal mucosa tissues (P Conclusions The higher tumor-infiltrating Tregs counts are closely associated with the improved prognostic effects of colon carcinoma. Tregs play different roles in cancer nest and cancer stroma. And the appearance of Tregs in cancer nest is a promising independent risk factor for overall survival in colon carcinoma. FOXP3-positive cancer cells may also be a risk factor for overall survival in colon carcinoma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In CRC, Tregs situated in the tumor mesenchyme result in a better prognosis, whereas Tregs residing in the tumor nests and infiltrating margins are linked to unfavorable clinical outcomes [142, 143].”
From Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review (2024) · cites this paper as [143]
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608 · cited 1×
“In particular the regulatory T cells (Tregs), these cells were first reported by (Sakaguchi et al. 1995) in both mice and humans as a key contributor to the maintenance of immunological tolerance and the prevention of autoimmunity.”
BackgroundCuriel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151 · cited 2×
“This finding seems to be consistent with other outcome studies in various human carcinomas (Curiel et al. 2004; Gao et al. 2007; Hiraoka et al. 2006; Jordanova et al. 2008; Li et al. 2009; Perrone et al. 2008; Petersen et al. 2006), in which the high accumulation of Tregs often results in a poor…”
BackgroundResultFOXP3+ regulatory T cells in the human immune system
Sakaguchi, S., Miyara, M., Costantino, C. M., & Hafler, D. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2785 · Cited by 2,439 · cited 2×
“tumor immune response by influencing the effect of CD4? and CD8? T cells, NK cells and myeloid cells, through different mechanisms (Sakaguchi et al. 2010).”
BackgroundEffector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135
Bates, G. J., Fox, S. B., Han, C., Leek, R. D., Garcia, J. F., Harris, A. L., & Banham, A. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9584 · Cited by 1,200 · cited 2×
“And a series of studies have revealed that the high tumor-infiltrating Tregs counts often associate with a poor prognosis in breast (Bates et al. 2006), ovarian (Curiel et al.”
BackgroundGao, Q., Qiu, S.-J., Fan, J., Zhou, J., Wang, X.-Y., Xiao, Y.-S., Xu, Y., Li, Y.-W., & Tang, Z.-Y. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4565 · Cited by 1,110 · cited 3×
“This finding seems to be consistent with other outcome studies in various human carcinomas (Curiel et al. 2004; Gao et al. 2007; Hiraoka et al. 2006; Jordanova et al. 2008; Li et al. 2009; Perrone et al. 2008; Petersen et al. 2006), in which the high accumulation of Tregs often results in a poor…”
BackgroundResultHori, S., Nomura, T., & Sakaguchi, S. (2017) · The Journal of Immunology · doi:10.1093/jimmunol/198.3.981 · Cited by 1,066
Cited by
FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
Saleh, R., & Elkord, E. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.022 · Cited by 352
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review
Li, Y., Zhang, C., Jiang, A., Lin, A., Liu, Z., Cheng, X., Wang, W., Cheng, Q., Zhang, J., Wei, T., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05104-y · Cited by 105
“In CRC, Tregs situated in the tumor mesenchyme result in a better prognosis, whereas Tregs residing in the tumor nests and infiltrating margins are linked to unfavorable clinical outcomes [142, 143].”
BackgroundZhao, Y., Ge, X., He, J., Cheng, Y., Wang, Z., Wang, J., & Sun, L. (2019) · World Journal of Surgical Oncology · doi:10.1186/s12957-019-1621-9 · Cited by 115
“In addition, as previously reported, only FOXP3+ Treg cell infiltration in cancer nests was associated with poor prognosis [47].”
BackgroundRelevance of Regulatory T Cells during Colorectal Cancer Development
Olguín, J. E., Medina-Andrade, I., Rodríguez, T., Rodríguez‐Sosa, M., & Terrazas, L. I. (2020) · Cancers · doi:10.3390/cancers12071888 · Cited by 89
“This was also associated with the frequency of Foxp3+ cells in patients with lymphatic invasion [53].”
Wang, Y., Li, J., Nakahata, S., & Iha, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137346 · Cited by 97
“In colorectal cancer (CRC), prognostic disparities are observed: Tregs within the tumor mesenchyme are linked to better outcomes, while those within the tumor nests and margins are associated with adverse patient prognoses [253,254].”
Background
Metadata
- Authors
- Xu, W., Liu, H., Song, J., Fu, H.-X., Qiu, L., Zhang, B.-F., Li, H.-Z., Bai, J., & Zheng, J.-N.
- Affiliations
- Affiliated Hospital of Xuzhou Medical College (CN)
- Xuzhou Medical College (CN)
- Corresponding author
- Bai, Jin
- Venue
- Journal of Cancer Research and Clinical Oncology
- Published
- 2013-09-05
- Volume
- 139
- Issue
- 11
- Pages
- 1845-1852
- ISSN
- 0084-5353 (ISSN-L)
- 0171-5216
- 1432-1335
- PMC
- PMC11824243
- OpenAlex
- W2002094191
- Cited by
- 31
- References
- 31
- Citations by year
- 2025: 5 · 2024: 4 · 2023: 2 · 2022: 1 · 2020: 4 · 2019: 3 · 2018: 4 · 2017: 2 · 2016: 3 · 2015: 2 · 2014: 1
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Cancer Research and Clinical Oncology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Keywords
- regulatory T cells, colon cancer, tumor-infiltrating lymphocytes, tumor stroma, prognostic factors, overall survival, lymphatic invasion, TNM stage, tumor microenvironment
- MeSH terms
- Adenocarcinoma, Aged, Colonic Neoplasms, Female, Humans, Immunohistochemistry, Lymphatic Metastasis, Male, Neoplasm Staging, Prognosis, Risk Factors, Lymphocytes, Tumor-Infiltrating, Paraffin Embedding, Tissue Array Analysis, T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The appearance of Tregs in cancer nest is a promising independent risk factor in colon cancer. https://app.cochat.ai/papers/10.1007/s00432-013-1500-7
- The paper
- Xu, W., Liu, H., Song, J., Fu, H.-X., Qiu, L., Zhang, B.-F., Li, H.-Z., Bai, J., & Zheng, J.-N. (2013). The appearance of Tregs in cancer nest is a promising independent risk factor in colon cancer. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-013-1500-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.